<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-09-27</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39327770/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">Assessing the hierarchical beta-binomial model as a basic information sharing tool in basket trials</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39327770-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The majority of statistical methods to share information in basket trials are based on a Bayesian hierarchical model with a common normal distribution for the logit-transformed response rates. The methods are of varying complexity, yet they all use this basic model. Generally, complexity is an obstacle for the application in clinical trials and that includes the use of the logit-transformation. The transformation complicates the model and impedes a direct interpretation of the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39327798/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">Mechanisms behind the high mortality rate in chronic Chagas cardiomyopathy: Unmasking a three-headed monster</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39327798-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Chagas disease is a neglected tropical disease caused by the parasite Trypanosoma cruzi. Chronic Chagas cardiomyopathy (CCC), the most severe form of target organ involvement in Chagas disease, is characterized by a complex pathophysiology and a unique phenotype that differentiates it from other cardiomyopathies, highlighting its worse prognosis compared to other aetiologies of heart failure. The three pathophysiological mechanisms with the largest impact on this differential mortality &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39327800/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">Bending the rules: A novel approach to laryngeal surgery in a body donor study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39327800-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The sMAC system effectively addresses challenges associated with transoral laryngeal surgery. Ongoing development aims to overcome current limitations of the system and prepare first clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39328074/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">Meeting the Needs of People With Severe Quadriplegia in the 21st Century: The Case for Implanted Brain-Computer Interfaces</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39328074-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Most importantly, the gap in digital equality fundamentally undermines the basic human rights of people with severe &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39329071/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">Effectiveness of the Medical Chatbot PROSCA to Inform Patients About Prostate Cancer: Results of a Randomized Controlled Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39329071-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS AND CLINICAL IMPLICATIONS: With the introduction of the PROSCA chatbot, we created and evaluated an innovative, evidence-based AI health information tool as an additional source of information for PC. Our RCT results showed significant benefits of the chatbot in reducing patients' information needs and enhancing their understanding of PC. This easy-to-use AI tool provides accurate, timely, and accessible support, demonstrating its value in the PC diagnosis process. Future &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39329251/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">A Negatively Curved Nanographene with Four Embedded Heptagons</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39329251-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Negatively curved nanographenes are considered as cutouts of three-dimensional fully spÂ²-hybridized carbon allotropes such as Schwarzites. Here we present the synthesis of a C(76) cut-out of the Schwarzite 8-4-1-p proposed by Lenosky et al. and investigate its optical as well as electrochemical properties. Furthermore, supramolecular interactions with fullerenes C(60) and C(70) were &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39329430/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">Exploring PKG signaling as a therapeutic avenue for pressure overload, ischemia, and HFpEF</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39329430-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Heart failure (HF) is a complex and heterogeneous syndrome resulting from any diastolic or systolic dysfunction of the cardiac muscle. In addition to comorbid conditions, pressure overload, and myocardial ischemia are associated with cardiac remodeling which manifests as extracellular matrix (ECM) perturbations, impaired cellular responses, and subsequent ventricular &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39329449/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">DNA methylation as a new tool for the differential diagnosis between T-LBL and lymphocyte-rich thymoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39329449-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    T-lymphoblastic lymphoma (T-LBL) and thymoma are two rare primary tumors of the thymus deriving either from T-cell precursors or from thymic epithelial cells, respectively. Some thymoma subtypes (AB, B1, and B2) display numerous reactive terminal deoxynucleotidyl transferase-positive (TdT^(+)) T-cell precursors masking epithelial tumor cells. Therefore, the differential diagnosis between T-LBL and TdT^(+) T-lymphocyte-rich thymoma could be challenging, especially in the case of needle biopsy. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39330692/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">How Far Is the Nanocellulose Chip and Its Production in Reach? A Literature Survey</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39330692-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The slowdown of Moore&rsquo;s Law necessitates an exploration of novel computing methodologies, new materials, and advantages in chip design. Thus, carbon-based materials have promise for more energy-efficient computing systems in the future. Moreover, sustainability emerges as a new concern for the semiconductor industry. The production and recycling processes associated with current chips present huge environmental challenges. Electronic waste is a major problem, and sustainable solutions &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39330962/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240927184326&amp;v=2.18.0.post9&#43;e462414">Celebrating Public Health</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39330962-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240927184326-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39330966/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240927184326&amp;v=2.18.0.post9&#43;e462414">Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39330966-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240927184326-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In a three-dose schedule (two primary doses and a booster), 40% doses of PCV13 were noninferior to full doses for all included serotypes. Lower doses of PCV13 and PCV10 did not meet the criteria for noninferiority. (Funded by the Bill and Melinda Gates Foundation and others; ClinicalTrials.gov number, NCT03489018; Pan African Clinical Trial Registry number, PACTR202104717648755.). &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39331066/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">Reconstruction of severe acetabular defects (Paprosky type III A) in total hip arthroplasty using modular tantalum augments in combination with a cemented cup</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39331066-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: This study has demonstrated good mid-term (mean 4.5 years) clinical and radiological outcomes of modular tantalum TM augments in combination with a cemented cup for the reconstruction of major acetabular defects. Mean blood tantalum concentrations were increased in patients with stable tantalum implants compared to healthy &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39331123/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39331123-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Mitogen-activated protein kinase kinase kinase kinase 1 (MAP4K1) is a serine/threonine kinase that acts as an immune checkpoint downstream of T-cell receptor stimulation. MAP4K1 activity is enhanced by prostaglandin E2 (PGE2) and transforming growth factor beta (TGFÎ²), immune modulators commonly present in the tumor microenvironment. Therefore, its pharmacological inhibition is an attractive immuno-oncology concept for inducing therapeutic T-cell responses in cancer patients. Here, we &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OyTL3i4rv">æ°å ç«èææé«è¿ç¤æ£èæ»ä½çå­ãä»å¤©Biocenturyè®²å°äº2024å¹´ESMOï¼æ¬§æ´²è¿ç¤å­¦ä¼å¹´ä¼ï¼ä¸ä¸ªéå¸¸æææçæ¥èªMD Andersonçç ç©¶ï¼æè¦995 MOï¼ï¼è¯¥ç ç©¶åç°æ¥ç§...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oytl3i4rv/">
    
    
    
    
    
      
    
    æ°å ç«èææé«è¿ç¤æ£èæ»ä½çå­ãä»å¤©Biocenturyè®²å°äº2024å¹´ESMOï¼æ¬§æ´²è¿ç¤å­¦ä¼å¹´ä¼ï¼ä¸ä¸ªéå¸¸æææçæ¥èªMD Andersonçç ç©¶ï¼æè¦995 MOï¼ï¼è¯¥ç ç©¶åç°æ¥ç§äºæ°å COVID mRNAç«èçè½¬ç§»æ¶æ§é»è²ç´ ç¤æ£èæ»ä½çå­çï¼OSï¼æé«ãç¾çè¿å±å»¶ç¼ï¼å½ç¶ï¼ç»è®¡åæçæ¶åè¦é¤å¤COVID mRNAåå°æ£èåçCOVIDå¯¹æ£èé¢åçå½±åï¼ãç ç©¶è¿ä¸æ­¥åç°æ¥ç§COVID-19 mRNAç«èéå°ç»èèºçæ£èï¼NSCLCï¼å¨æ¥ç§ç«è100å¤©ååç©¿åºæ´»æ£ï¼ç«èæ¥ç§èè¿ç¤ç»ç»PD-L1è¡¨è¾¾ä¸è°ï¼å æ­¤å¯¹PD-1/PD-L1æ®æååºç­æ´å¥½ã<!-- raw HTML omitted --><!-- raw HTML omitted -->æä¸ä¸ä¸ªå·¥ä½ç ç©¶mRNAç«èå¨æ°å COVIDåHIVä¸­çåºç¨ã2022å¹´åºï¼MerckåModernaæ¥éäºå¶è¿ç¤æ²»çmRNAç«èmRNA-4157åKeytrudaèåæ²»çå°III/IVææ¶æ§é»è²ç´ ç¤æ­»äº¡åå¤åéä½44%ç2æä¸´åºè¯éªç»æï¼è¿ä¸ç»æå¨2023å¹´AACRä¸è¢«è¿ä¸æ­¥æ¥éï¼&lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OyZyNfMxa">ç¾å½å«çé¨åå¼å§åè´¹åæ¾COVIDæ£æµè¯åçäºï¼æ¯å®¶å¯ä»¥é¢4ä¸ªï¼USPSåè´¹é®å¯ç½ç«é¾æ¥ï¼ç½é¡µé¾æ¥ - è½¬å @å­éµå¨å¬æ­:&amp;ensp;éè¦çä¿¡æ¯ãç¾å½å¤å­£ç»åäºä¸ä¸ªCOVID...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oyzynfmxa/">
    
    
    
    
    
      
    
    ç¾å½å«çé¨åå¼å§åè´¹åæ¾COVIDæ£æµè¯åçäºï¼æ¯å®¶å¯ä»¥é¢4ä¸ªï¼USPSåè´¹é®å¯ç½ç«é¾æ¥ï¼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½é¡µé¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@å­éµå¨å¬æ­<!-- raw HTML omitted -->:âéè¦çä¿¡æ¯ãç¾å½å¤å­£ç»åäºä¸ä¸ªCOVIDç«æå°é«å³°ï¼è½ç¶æè¿COVIDç«æææç¼è§£ï¼ä½ç½å®«å®£å¸èª9æ25æ¥å°éæ°å¼å§åè´¹åç¾å½å±æ°åæ¾æ£æµè¯åçï¼æ¯å®¶ï¼householdï¼å¯ä»¥é¢å4ä¸ªãé¢åç½ç«ä¸åæ¥ä¸æ ·ï¼&lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyXEmieLx">ð»è¯´ççï¼æ¥æ¬äººéè°é½æ¯ä¹å­ãð»æ¯å¦ï¼è¿æ¯æ§è½¬ä¸æ¡äºç­åµé­æäººé«å¸æ©èæ¼å±çãRusty Nailã#ç³ç ´èå°åºä»»æ¥æ¬é¦ç¸##ç­é¨è§é¢# åå®¹ä¸ç©ææ²³æ°´çå¾®åè§...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxemielx/">
    
    
    
    
    
      
    
    ð»è¯´ççï¼æ¥æ¬äººéè°é½æ¯ä¹å­ã<!-- raw HTML omitted -->ð»æ¯å¦ï¼è¿æ¯æ§è½¬ä¸æ¡äºç­åµé­æäººé«å¸æ©èæ¼å±çãRusty Nailã<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ç³ç ´èå°åºä»»æ¥æ¬é¦ç¸#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyXGIhJ3k">ð»è«ä¼è°¢è¶å¤«è­è¾èå¢æ¼åçæ¼æµ®èè¹æå·§ã#ç­é¨è§é¢# åå®¹ä¸ç©ææ²³æ°´çå¾®åè§é¢</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxgihj3k/">
    
    
    
    
    
      
    
    ð»è«ä¼è°¢è¶å¤«è­è¾èå¢æ¼åçæ¼æµ®èè¹æå·§ã<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ç­é¨è§é¢#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åå®¹ä¸ç©ææ²³æ°´çå¾®åè§é¢<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;div style=&ldquo;clear: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyXIjwvVk">ð»ç¾å½æµ·å²¸è­¦å«éå¨æµ·ä¼¦é£é£æ¥ä¸´ä¹åï¼ä»ä¸æ¡å¤±æ§å¸è¹ä¸æäºä¸ä¸ªäººåä»ççãð»via uscoastguard#ç­é¨è§é¢# åå®¹ä¸ç©ææ²³æ°´çå¾®åè§é¢</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxijwvvk/">
    
    
    
    
    
      
    
    ð»ç¾å½æµ·å²¸è­¦å«éå¨æµ·ä¼¦é£é£æ¥ä¸´ä¹åï¼ä»ä¸æ¡å¤±æ§å¸è¹ä¸æäºä¸ä¸ªäººåä»ççã<!-- raw HTML omitted -->ð»via uscoastguard<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ç­é¨è§é¢#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åå®¹ä¸ç©ææ²³æ°´çå¾®åè§é¢<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;br &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyXJgCn65">ð»éº»çå¤ªéæ¯ä¸æ¯ç©ä¸èµ·ï¼#ç³ç ´èå°åºä»»æ¥æ¬é¦ç¸##ç­é¨è§é¢# åå®¹ä¸ç©ææ²³æ°´çå¾®åè§é¢</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxjgcn65/">
    
    
    
    
    
      
    
    ð»éº»çå¤ªéæ¯ä¸æ¯ç©ä¸èµ·ï¼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ç³ç ´èå°åºä»»æ¥æ¬é¦ç¸#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ç­é¨è§é¢#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://video.weibo">https://video.weibo</a>. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyXJjFbBQ">ð»å¨ð°ðµæé²ä¸æµ·è¾¹å¸å´éè¿é£æ¯ç§ä¸½çé©¬åºæµ·æ°´æµ´åºåæ¬¡åå¤å½æ¸¸å®¢å¼æ¾ãð»via vk#ç­é¨è§é¢# åå®¹ä¸ç©ææ²³æ°´çå¾®åè§é¢</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxjjfbbq/">
    
    
    
    
    
      
    
    ð»å¨ð°ðµæé²ä¸æµ·è¾¹å¸å´éè¿é£æ¯ç§ä¸½çé©¬åºæµ·æ°´æµ´åºåæ¬¡åå¤å½æ¸¸å®¢å¼æ¾ã<!-- raw HTML omitted -->ð»via vk<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ç­é¨è§é¢#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åå®¹ä¸ç©ææ²³æ°´çå¾®åè§é¢<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;div &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyXKDbs4n">ð»å«è¿æ ·ï¼å¥ä»¬å¿#Aè¡æ­£ä»åå¼¹èµ°ååè½¬# [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxkdbs4n/">
    
    
    
    
    
      
    
    ð»å«è¿æ ·ï¼å¥ä»¬å¿<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#Aè¡æ­£ä»åå¼¹èµ°ååè½¬#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyXLH6h4P">ð»ï¼æ²¡æåï¼#æ­¦æ±éæ# [å¾ç][å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxlh6h4p/">
    
    
    
    
    
      
    
    ð»ï¼æ²¡æåï¼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#æ­¦æ±éæ#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyXOz1GAQ">ð»ç¼ç®éä¹æ²¡çå°ã#æ­¦æ±éæ# [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxoz1gaq/">
    
    
    
    
    
      
    
    ð»ç¼ç®éä¹æ²¡çå°ã<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#æ­¦æ±éæ#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyXW8vtct">ð»å è¤èä¿¡ä»å¤©ä¸å¬å¼æ¯æä»ç«éèªæ°ååéäººçè®®åä»¬å±è¿åé¤ï¼åäºä¸é¡¿ä¼ ç»çåå±çªæé¥­ï¼åé¥­çä¸å±æ 20 äººãð»å¨ç¬¬ä¸è½®æç¥¨ä¸­ï¼å è¤åªå¾å°äº 16 ç¥¨ï¼è¿...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxw8vtct/">
    
    
    
    
    
      
    
    ð»å è¤èä¿¡ä»å¤©ä¸å¬å¼æ¯æä»ç«éèªæ°ååéäººçè®®åä»¬å±è¿åé¤ï¼åäºä¸é¡¿ä¼ ç»çåå±çªæé¥­ï¼åé¥­çä¸å±æ 20 äººã<!-- raw HTML omitted -->ð»å¨ç¬¬ä¸è½®æç¥¨ä¸­ï¼å è¤åªå¾å°äº 16 ç¥¨ï¼è¿æå³çæ 4 ä¸ªåäºåå±çªæé¥­çäººèåäºä»ã<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ç³ç ´èå°åºä»»æ¥æ¬é¦ç¸#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/639b1bfbly1hu2m3kx3cxj20qo1bdk2g.jpg%22">https://tvax2.sinaimg.cn/large/639b1bfbly1hu2m3kx3cxj20qo1bdk2g.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyXXack5n">åæå®å¯ï½æ¯ä¸æ¯èé©¬æ²¡å¼æºçé½æ¯å¨ç»åï¼//@é©¬ä¸é¾æ æåææ¯:åå¤@åäºä»å¤©çä¹¦äºå:ç«ç®­æ²¡ç»æµåï¼ç©¿è¶æºå¯ä»¥éæçæåä¿¯æè¿è½å¨ç«ç®­ä¸é¢ä»°æï¼å±ç¶ä¹æ²¡å...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxxack5n/">
    
    
    
    
    
      
    
    åæå®å¯ï½æ¯ä¸æ¯èé©¬æ²¡å¼æºçé½æ¯å¨ç»åï¼//<!-- raw HTML omitted -->@é©¬ä¸é¾æ æåææ¯<!-- raw HTML omitted -->:åå¤<!-- raw HTML omitted -->@åäºä»å¤©çä¹¦äºå<!-- raw HTML omitted -->:ç«ç®­æ²¡ç»æµåï¼ç©¿è¶æºå¯ä»¥éæçæåä¿¯æè¿è½å¨ç«ç®­ä¸é¢ä»°æï¼å±ç¶ä¹æ²¡åå°ç»æµå½±åï¼è¿æ¯ä»ä¹nbè®¾å¤ï¼èä¸çç¸ç¬é´ççé¾ï¼æè§å¾åâ¦ èä¸æ´ä½çç»é¢ä¸ä¸åªç¹é½æ²¡æï¼çè³çç¸é½æ²¡ï¼å¤ªæ¯æ·¡äº//<!-- raw HTML omitted -->@é©¬ä¸é¾æ æåææ¯<!-- raw HTML omitted -->:æ¾ç¶å°±æ¯å¨ç»//&lt;a href=&ldquo;<a href="https://weibo.com/n/%E8%A2%AB%E5%8A%A8%E8%A2%AB%E5%8A%25">https://weibo.com/n/%E8%A2%AB%E5%8A%A8%E8%A2%AB%E5%8A%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OyWrcFcU6">ä¹ä¿å²ç»ªé via.nogizaka_goods [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oywrcfcu6/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --> via.nogizaka_goods <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OyX1MzlBn">ä¹ä¿å²ç»ªé via.ç·è¡è®°fb [å¾ç][å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oyx1mzlbn/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --> via.ç·è¡è®°fb <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1hu2i4b3jwsj30u00k">https://tvax1.sinaimg.cn/large/006z6nxLgy1hu2i4b3jwsj30u00k</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OyYVAwBPh">ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.09.25 11:55ãæ¬¸å¿å¿ãæ©ä¸å¥½ãæ³åçäºæãå¿é¡»è¦åçäºæè½ç¶å ç§¯å¦å±±ï¼ä½ææç®å¥½å¥½å©ç¨æ¶é´éä¸æ´çâ¦ï¼ï¼æ©ä¸å¼å§å°±å...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oyyvawbph/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OyYWth7y5">ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.09.25 11:56(è¡¥)ãåå¼å¼ãDARSï¼è¯·ä¸å®è¦ççå¹¿åå¦ãï¼ï¼ï¼ä¸ç´å¨è·³èâºï¸ä¼æ¯å®¤éæä¸ç´è·æä¸ªå¥³å­©ä¸ç´å¾å¨ä¸èµ·ãå¤§æ¦å°±...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oyywth7y5/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpa">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpa</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OyYZz1sX9">ä¹ä¿å²ç»ªé#shiorigram# æ£çå°å¥³é¹«å°¾@ comicé¹«å°¾å¸æä¿æä¹å¤©æ¼«ç»ä»å¤©åå®â¦ðç»äºè¦åå®äºâ¦ï¼ï¼è¯·ä¸å®è¦å¥æðä¹æ¨å46ANNçæ ç®åææ¼«ç»â¦åæ¯èæ ç¼¥ç¼...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oyyzz1sx9/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39323550/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">The roles of TAF1 in neuroscience and beyond</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39323550-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The transcriptional machinery is essential for gene expression and regulation; dysregulation of transcription can result in a range of pathologies, including neurodegeneration, cancer, developmental disorders and cardiovascular disease. A key component of RNA polymerase II-mediated transcription is the basal transcription factor IID, which is formed of the TATA box-binding protein (TBP) and 14 TBP-associated factors (TAFs), the largest of which is the TAF1 protein, encoded on the X &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39323563/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">Reimagining India&#39;s National Telemedicine Service to improve access to care</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39323563-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    India&rsquo;s free-to-use National Telemedicine Service, eSanjeevani, has provided over 276 million consultations and shown promise to reduce systemic inequalities in access to care. However, recent reports of dropping footfall have raised questions about the potential of eSanjeevani to bridge service provision gaps in India. We reveal important problems linked to the design and practice of triage and tele-referral nationally within eSanjeevani, corroborated by the experience of one of the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39323707/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">Intraspinal Intradural Arachnoid Web at the Thoracic Level: A Case Report</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39323707-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Arachnoid web is a rare condition, which can cause significant neurological symptoms due to spinal cord compression. This case highlights the clinical presentation, surgical management, and pathology of an arachnoid web, contributing to the understanding of this rare condition. A 68-year-old female presented with diffuse pain syndrome, gait disturbance, and left leg pain. Clinical-neurological examination indicated myelopathy, confirmed by magnetic resonance imaging (MRI) revealing &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39323919/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">ChatGPT and generative AI in urology and surgery-A narrative review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39323919-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The potential of ChatGPT and related generative AI models are vast, heralding the beginning of a new era where AI may eventually become integrated seamlessly into surgical practice. Concerns with this new technology must not be disregarded in the urge to hasten progression, and potential risks impacting patients' interests must be considered. Appropriate regulation and governance of this technology will be key to optimising the benefits and addressing the intricate challenges &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39324060/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">SIMUnet: an open-source tool for simultaneous global fits of EFT Wilson coefficients and PDFs</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39324060-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We present the open-source SIMUnet code, designed to fit Standard Model Effective Field Theory (SMEFT) Wilson coefficient alongside Parton Distribution Functions (PDFs) of the proton. SIMUnet can perform SMEFT global fits, as well as simultaneous fits of the PDFs and of an arbitrarily large number of SMEFT degrees of freedom, by including both PDF-dependent and PDF-independent observables. SIMUnet can also be used to determine whether the effects of any New Physics models can be fitted away in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39324163/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">Formalized peer referral to HIV pre-exposure prophylaxis supported with self-testing: a mixed-methods pilot study among young Kenyan women</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39324163-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: A formalized model of peer referral with HIVST delivery supported PrEP initiation among Kenyan AGYW. These findings demonstrate the potential for peer-delivered interventions to engage AGYW in HIV prevention services; however, more research is needed on the effectiveness and sustainability of this approach at &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39324397/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">Genome-wide meta-analysis of ascertainment and symptom structures of major depression in case-enriched and community cohorts</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39324397-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The results show the importance of assessing the directionality of symptoms (such as hypersomnia versus insomnia) and of accounting for study and measurement design when meta-analyzing genetic association &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39324686/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">Sleep and long COVID: preexisting sleep issues and the risk of PASC in a large general population using 3 different model definitions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39324686-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Insomnia, poor sleep quality and short sleep duration are cross-sectionally associated with PASC and may be potential risk factors. Further longitudinal studies should be &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39324691/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">Evaluation of automated pediatric sleep stage classification using U-Sleep: a convolutional neural network</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39324691-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: While U-Sleep algorithms showed statistically equivalent performance to trained scorers, accuracy was lower in children &lt; 2 years and those with sleep-disordered breathing or comorbidities affecting electroencephalography. U-Sleep is suitable for pediatric clinical utilization provided automated staging is followed by expert clinician &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39324856/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">Iron Complexes of 4,5-Bis(diorganophosphinomethyl)acridine Ligands</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39324856-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The search for an iron analog of the established ruthenium-based catalysts containing methylene-extended 4,5-bis(diorganophosphinomethyl)acridine ligands, [FeHCl(CO)(L^(R))], resulted in the discovery of a bidentate coordination mode of these usually tridentate pincer ligands toward iron. The acridines nitrogen atom does not coordinate to iron, leading to the formation of iron diphos-type complexes with unusually large cis bite angles of up to 124Â° as well as trans bite angles around 155Â°. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39324900/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1jUKNaekwK5-jhnLOsYRQeEvu-lGfd382Ao3uOl7PziqjjxYZK&amp;fc=20220919201732&amp;ff=20240926193903&amp;v=2.18.0.post9&#43;e462414">Viral infection after hematopoietic stem cell transplantation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39324900-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1juknaekwk5-jhnlosyrqeevu-lgfd382ao3uol7pziqjjxyzk-fc-20220919201732-ff-20240926193903-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    PURPOSE OF REVIEW: Viral infections are important complications after allogeneic hematopoietic stem cell transplantation. New infections develop such as SARS-CoV-2 with the potential for severe consequences. In this review, newly published information regarding management of viral infections is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39324900/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1jUKNaekwK5-jhnLOsYRQeEvu-lGfd382Ao3uOl7PziqjjxYZK&amp;fc=20220919201732&amp;ff=20240927184317&amp;v=2.18.0.post9&#43;e462414">Viral infection after hematopoietic stem cell transplantation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39324900-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1juknaekwk5-jhnlosyrqeevu-lgfd382ao3uol7pziqjjxyzk-fc-20220919201732-ff-20240927184317-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    PURPOSE OF REVIEW: Viral infections are important complications after allogeneic hematopoietic stem cell transplantation. New infections develop such as SARS-CoV-2 with the potential for severe consequences. In this review, newly published information regarding management of viral infections is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325040/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">Pre-operative anaemia in nonagenarians and centenarians undergoing hip fracture surgery: A retrospective cohort study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325040-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325081/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">An Artificial Intelligence Algorithm Integrated into the Clinical Workflow Can Ensure High Quality Acute Intracranial Hemorrhage CT Diagnostic</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325081-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: We showed that an AI algorithm for the automatic detection of ICHs can be seamlessly integrated into clinical workflows with minimal turnaround time. The accuracy was on par with radiology experts, making the system suitable for routine clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325140/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">POSE-2 for patients with obesity: a safe and effective treatment option</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325140-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325141/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">Irradiation alters extracellular vesicle microRNA load in the serum of patients with leukaemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325141-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: As compared to healthy controls and following irradiation, we have identified differentially regulated miRNAs in serum-derived EVs from patients with leukaemia that may serve as possible biomarkers of leukaemic disease and treatment and radiation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325200/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">Psychotherapeutic approaches to crises</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325200-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Understanding early relational experiences based on psychodynamic or learning theory processes influences the application of further crisis intervention techniques and their impact on affected &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325381/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">An exploration of physics envy with implications for desiderata of psychology theories</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325381-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    There is a trepidation, anxiety, or intuition, which has persisted for more than a century, that psychology theories are less anchored in fundamental laws than physics theories. Rather than attempt to refute the concern, the present work accepts it and tries out candidate explanations. These pertain to empirical laws, parsimony, scope, reductionism, falsifiability, mathematical operations (multiplication vs. addition), internal coherence, ceteris paribus stipulations, and purposeful omission &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325395/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">Interpersonal emotion regulation and depressive symptoms in parent-adolescent dyads: A daily-diary investigation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325395-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Deficient parental extrinsic interpersonal emotion regulation (IER, how people regulate others' emotions) is a known risk factor for adolescent depression. Although IER and depression development are transactional, dyadic processes, previous work has almost exclusively focused on how parental IER is associated with adolescent depression. The association between parental IER and adolescent depression, and the associations between adolescent IER and adolescent and parental depression have &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325479/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240926193913&amp;v=2.18.0.post9&#43;e462414">Targeting PKCÎ± decreases iron overload in diabetes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325479-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240926193913-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325479/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240927184325&amp;v=2.18.0.post9&#43;e462414">Targeting PKCÎ± decreases iron overload in diabetes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325479-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240927184325-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325480/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240926193913&amp;v=2.18.0.post9&#43;e462414">Pirtobrutinib combinations in CLL</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325480-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240926193913-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325480/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240927184325&amp;v=2.18.0.post9&#43;e462414">Pirtobrutinib combinations in CLL</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325480-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240927184325-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325481/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240926193913&amp;v=2.18.0.post9&#43;e462414">Targeting DUX4-r leukemia via PI3K and CD371</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325481-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240926193913-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325481/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240927184325&amp;v=2.18.0.post9&#43;e462414">Targeting DUX4-r leukemia via PI3K and CD371</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325481-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240927184325-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325482/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240926193913&amp;v=2.18.0.post9&#43;e462414">Pyridoxine: beyond a cofactor of ALAS</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325482-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240926193913-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325482/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240927184325&amp;v=2.18.0.post9&#43;e462414">Pyridoxine: beyond a cofactor of ALAS</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325482-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240927184325-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325483/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240926193913&amp;v=2.18.0.post9&#43;e462414">ALK-positive anaplastic large cell lymphoma, Hodgkin-like pattern with unexplained fever</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325483-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240926193913-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325483/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240927184325&amp;v=2.18.0.post9&#43;e462414">ALK-positive anaplastic large cell lymphoma, Hodgkin-like pattern with unexplained fever</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325483-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240927184325-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325484/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240926193913&amp;v=2.18.0.post9&#43;e462414">T-ALL and T-LBL: a notch apart</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325484-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240926193913-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325484/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240927184325&amp;v=2.18.0.post9&#43;e462414">T-ALL and T-LBL: a notch apart</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325484-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240927184325-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325485/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240926193913&amp;v=2.18.0.post9&#43;e462414">CARdinal signs of variant ICANS</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325485-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240926193913-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325485/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240927184325&amp;v=2.18.0.post9&#43;e462414">CARdinal signs of variant ICANS</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325485-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240927184325-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325928/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">Long-term care insurance in China: Current challenges and recommendations</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325928-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39325999/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">Adaptive Trials in Stroke: Current Use and Future Directions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39325999-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Inclusion of adaptive design features in a clinical trial provides preplanned flexibility to dynamically modify a trial during its conduct while preserving validity and integrity. Adaptive trials are needed to accelerate the conduct of more efficient, informative, and ethical clinical research in the field of neurology. Stroke is a natural candidate for adoption of these innovative approaches to trial design. This Research Methods in Neurology article is informed by a scoping review &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39326046/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240926193917&amp;v=2.18.0.post9&#43;e462414">Changes in 10-Year Predicted Cardiovascular Disease Risk for a Multiethnic Semirural Population in South East Asia: Prospective Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39326046-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240926193917-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Sociodemographics and mental health were found to be differently associated with CVD risk trajectories, warranting future research to disentangle the role of psychosocial disparities in CVD. Our findings carry public health implications, suggesting that the rise in major risk factors along with psychosocial disparities could potentially elevate CVD risk among individuals in underserved settings. More prevention efforts that continuously monitor CVD risk and consider changes in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39326645/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">Outcome after treatment with axitinib in children, young adults, and adults with renal cell carcinoma: a narrative review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39326645-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Renal cell carcinoma (RCC) is a very rare type of renal cancer in children and young adults. When metastasized or recurrent, no standards of care are available, and outcome is still poor. The tyrosine kinase inhibitor axitinib is approved for treatment of RCC in adults, but its effects in children and young adults with RCC remains unclear. Due to the histological and biological differences between children and adults, it is difficult to extrapolate knowledge on treatments from the adult to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39326671/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on ICU patient prognosis: a causal inference approach using data from the Eurobact2 study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39326671-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In patients with HA-BSI admitted in ICU, the PAF of 28-day mortality of inadequate therapy within 24 hours was 9.15%. This estimate should be used when hypothesizing the possible benefit of any intervention aiming at reducing the time-to-appropriate antimicrobial therapy in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39326782/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">Candidate antibody reference reagents for Chlamydia trachomatis serology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39326782-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Chlamydia trachomatis (Ct) serology is an important tool for monitoring infection and disease burden but there are currently no formal reference reagents to harmonize results reporting. Our objective was to develop a panel of candidate reference reagents with reactivity against the major outer membrane protein (MOMP) and virulence factor (pgp3) antigens. Plasma packs from females (20-40 years old) were screened against MOMP and pgp3 antigens and selected positive and negative samples pooled &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39326896/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">Prevalence and associations of parapapillary scleral ridges: the Beijing Eye Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39326896-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: With a PSR prevalence of &gt;60% in eyes with an axial length of &gt;28 mm, PSRs are a common morphological feature of high myopia, with age and female sex as additional associated factors. PSRs may be due to a biomechanical interplay between the optic nerve and the posterior ocular segment of markedly axially elongated &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39327338/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">The German research consortium for the study of bipolar disorder (BipoLife): a quality assurance protocol for MR neuroimaging data</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39327338-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: The German multicenter research consortium BipoLife aims to investigate the mechanisms underlying bipolar disorders. It focuses in particular on people at high risk of developing the disorder and young patients in the early stages of the disease. Functional and structural magnetic resonance imaging (MRI) data was collected in all participating centers. The collection of neuroimaging data in a longitudinal, multicenter study requires the implementation of a comprehensive &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39327353/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">Anti-PD-L1 blockade facilitates antitumor effects of radiofrequency ablation by improving tumor immune microenvironment in hepatocellular carcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39327353-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Hepatocellular carcinoma (HCC) is a complex disease with advanced presentation that significantly affects survival rates. Therefore, novel therapeutic strategies are needed. In this study, we investigate the tumor microenvironment (TME) in HCC by analyzing 13 HCC samples at single cell level. We identified key cell populations, including CD8 + T cells, Tregs, M1/M2 macrophages, and CD4 + memory T cells, and explored their roles and interactions. Our research revealed an early enrichment of CD8 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39327420/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">Enhanced feature matching in single-cell proteomics characterizes IFN-Î³ response and co-existence of cell states</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39327420-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Proteome analysis by data-independent acquisition (DIA) has become a powerful approach to obtain deep proteome coverage, and has gained recent traction for label-free analysis of single cells. However, optimal experimental design for DIA-based single-cell proteomics has not been fully explored, and performance metrics of subsequent data analysis tools remain to be evaluated. Therefore, we here formalize and comprehensively evaluate a DIA data analysis strategy that exploits the co-analysis &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39327434/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">Long-term oxygen therapy in precapillary pulmonary hypertension - SOPHA study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39327434-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Current guidelines recommend oxygen (O(2)) supplementation in patients with pulmonary hypertension (PH), despite scarce data on long-term O(2) therapy (LTOT). The aim of this prospective, randomized, controlled trial was to investigate the effect of LTOT in patients with precapillary PH on exercise capacity, clinical parameters and hemodynamics. Patients with precapillary PH under stable therapy and O(2) desaturations at rest and/or during exercise were randomized to receive LTOT (â¥ 16 h/day) &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39327458/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240927184334&amp;v=2.18.0.post9&#43;e462414">A systemic look at pancreatic cancer patients: Predicting metastasis by studying the liver</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39327458-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240927184334-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39327464/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240927184326&amp;v=2.18.0.post9&#43;e462414">Can PROTACs cure Leukemia?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39327464-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240927184326-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OyJuY9rzd">å¾å¤äººè¯¢é®åè½¬åçâç­æâ â åäº¬å¤§å­¦å¼åçç¾é©¼çº³ç±³æä½çç ç©¶å¨æ­¤ãè¿æ¯ä¸ªè¿äºå¹´æ¯è¾æ´»è·çææ¯ï¼å¹¶ä¸æ¯éç¨ç¢å¼ççªç ´ãCD4åæç¨äºHIVæ²»ççè¯ç©å·²ç»ä¸å¸...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oyjuy9rzd/">
    
    
    
    
    
      
    
    å¾å¤äººè¯¢é®åè½¬åçâç­æâ â åäº¬å¤§å­¦å¼åçç¾é©¼çº³ç±³æä½çç ç©¶å¨æ­¤ãè¿æ¯ä¸ªè¿äºå¹´æ¯è¾æ´»è·çææ¯ï¼å¹¶ä¸æ¯éç¨ç¢å¼ççªç ´ãCD4åæç¨äºHIVæ²»ççè¯ç©å·²ç»ä¸å¸äºå¤å¹´ï¼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½é¡µé¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼ï¼ä½å¶åªåä¸ºå¤èè¯æ¹æ¡ï¼èä¸æ¯ä¸çº¿ãäºçº¿æ¹æ¡ãå¦å¤ï¼åå¤å¼ºè°çï¼HIVä¸è½æ²»æä¸æ¯å ä¸ºæ²¡æææçæ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OyKyVktwc">ä»å¤©ä¸­åæ¯æ´ä¸ªDé¨é¨çåé¤ï¼åå¨æå¯¹é¢çå ä¸ªä¸­å½ç§å­¦å®¶é½æ¯data scientistï¼æå¾æå´è¶£å°å¬ä»ä»¬çå·¥ä½åå®¹ï¼å­¦ä¹ å°äºå¾å¤ä¸è¥¿ãå¨ä¹åçæºæï¼data scienceå...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oykyvktwc/">
    
    
    
    
    
      
    
    ä»å¤©ä¸­åæ¯æ´ä¸ªDé¨é¨çåé¤ï¼åå¨æå¯¹é¢çå ä¸ªä¸­å½ç§å­¦å®¶é½æ¯data scientistï¼æå¾æå´è¶£å°å¬ä»ä»¬çå·¥ä½åå®¹ï¼å­¦ä¹ å°äºå¾å¤ä¸è¥¿ãå¨ä¹åçæºæï¼data scienceåç»è®¡åºæ¬é½å¨ä¸ä¸ªé¨é¨ï¼èè½ä¹ä¸åºåãä½ä»å¤©äºè§£å°ï¼å¨è¯åè¿åå±ä¸¤ä¸ªé¨é¨ãData scienceæ´ä¾§éç§ç ï¼ç»è®¡æ´ä¾§éä¸´åºãèè¿æ ·è®¾è®¡æ¯é¢æç¨æçã<!-- raw HTML omitted --><!-- raw HTML omitted -->Data scienceï¼informaticsï¼å¤§éå·¥ä½æ¯éè¿ç¼ç¨å»ºæ¨¡çï¼ç°å¨æ´æ³¨éAIåMLï¼æ¹æ³æ´å¼æ¾åå¼æºï¼åºç¨ä¹æ´å¹¿æ³ï¼æ¯å¦è¿è¡æ¶ä¸æµè¡çå¤ç»å­¦åæãé¢æµè¯ç©çæãä½¿ç¨AIæ¥è¯å«æ½å¨çåéè¯ç©ãå¹¶è¿è¡çå®ä¸çåæï¼RWEï¼ã<!-- raw HTML omitted --><!-- raw HTML omitted -->èç»è®¡ç¨æ¨¡åè¾åºæ°æ®è¿è¡ç­éååæï¼æ¹æ³æ´ä¼ ç»ï¼æ¯å¦åè®¾æ£éªãæ¹å·®åæ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OyL8WoFn9">æå¨é¢è¯çæ¶åï¼å½æ¶ä¸åæ¾ç»æ¯å­¦æ ¡PIçæµè¡çå­¦å®¶è¯´ï¼æä¸è§å¾æä»»ä½ææ¯é¾é¢ä¼é¾åä½ ï¼ä½å·ææææ§çæ¯è·åç§æ§æ ¼çäººæäº¤éãå°ç°å¨æè§å¾è¿å¥è¯ç¹å«åç¨ã...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oyl8wofn9/">
    
    
    
    
    
      
    
    æå¨é¢è¯çæ¶åï¼å½æ¶ä¸åæ¾ç»æ¯å­¦æ ¡PIçæµè¡çå­¦å®¶è¯´ï¼æä¸è§å¾æä»»ä½ææ¯é¾é¢ä¼é¾åä½ ï¼ä½å·ææææ§çæ¯è·åç§æ§æ ¼çäººæäº¤éãå°ç°å¨æè§å¾è¿å¥è¯ç¹å«åç¨ãå¤§å®¶é½æ¯çå­¦æå»å­¦åå£«ï¼ææ¯ç¯èé½ä¸æé®é¢ãä½æ¯ï¼åæ¥ä½ å¯è½æ¯âbig fish in a small pondâï¼ç°å¨åè¦å­¦ä¼åå¾å¤æ´âçâçäººæäº¤éãæ´éè¦çæ¯ï¼å¾å¤äººå¯è½æ¯ä½ èªå·±è¿æçæ³åæ¿æï¼åæ¶ï¼å¾å¤äººæbig ego/big prideï¼è¿å°±å¥½æ¯å¨RUåPIæèå¨MGHè¡å»ä¸æ ·ï¼æ°¸è¿æ¯ä¸å±±è¿æä¸å±±é«ãå¼ºä¸­æ´æå¼ºä¸­æãè¿å°±è¦æ±å¨é«åº¦åä½çå²ä½ä¸ï¼å¦ä½è½å¤æå·¥ä½åå®åå¥½ï¼åä¸åä¸äº¢ãä¿æè´£ä»»å¿ï¼å¹¶ä¸è®©ç­æå·å´ï¼è¿è½å¤å®ç°èä¸çæ³ãè¿ä¸ªè¿ç¨å¨ç¾å½å«åwalk a fine &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OySsOlzGD">æ¯å¤©é½å¨æ´æ°ç¥è¯ï¼æ¯å¦èéæ¸é¤çåeGFRå¨ä¸åç§æä¸­æ¯ä¸ä¸æ ·çï¼å¥åº·éè£æ¯ç½äººèéæ°´å¹³è¦é«ï¼å æ­¤ä¸è½å»ç¨åæ ·çæ åãNIHæåå»ºè®®ç¨åºäºç§æçeGFRè®¡ç®æ¹å¼...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oyssolzgd/">
    
    
    
    
    
      
    
    æ¯å¤©é½å¨æ´æ°ç¥è¯ï¼æ¯å¦èéæ¸é¤çåeGFRå¨ä¸åç§æä¸­æ¯ä¸ä¸æ ·çï¼å¥åº·éè£æ¯ç½äººèéæ°´å¹³è¦é«ï¼å æ­¤ä¸è½å»ç¨åæ ·çæ åãNIHæåå»ºè®®ç¨åºäºç§æçeGFRè®¡ç®æ¹å¼æ´å®¢è§ãä»å¤©è·æçå»çè®¨è®ºäºPrEPç ç©¶ç»æï¼åè¯ä»äºLENçä¼å¿ï¼å¹¶ç»ä»åäºNEJM PURPOSE 1ç ç©¶ï¼ä»å¾æè°¢ï¼ä»å¸¦æçUCSFå»å­¦çå¨è®°ç¬è®°ã  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OyJVT0jyM">è¯­æ°ï¼åäºä¸å¿ï¼åäºä¹å¸ãä¸è½¦æç«åï¼ç¬¬ä¸ä»¶äºï¼æ£æ¥æ²¹è¡¨ã æé½Â·åå·å¤§å­¦(æ±å®æ ¡åº) [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-oyjvt0jym/">
    
    
    
    
    
      
    
    è¯­æ°ï¼åäºä¸å¿ï¼åäºä¹å¸ãä¸è½¦æç«åï¼ç¬¬ä¸ä»¶äºï¼æ£æ¥æ²¹è¡¨ã <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æé½Â·åå·å¤§å­¦(æ±å®æ ¡åº)<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OyJwQ65HL">å»å¹´ä¹ææ°çèªç±è¡ï¼ä¹é²æ¨é½-åä»-ä¼å®ï¼ä¼å®ä¹åï¼åå¤åå¾é¿åæ³°ï¼æ¸¸åææ¯æ¹ï¼ä½çç¤¾ç§é¢éè¯·æåå åå£«åå¼é¢æ¥åï¼æ¶é´å®å¨å½åºèåï¼ä¸è½æ´æ¹ï¼åªå¥½ç»æ­¢...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-oyjwq65hl/">
    
    
    
    
    
      
    
    å»å¹´ä¹ææ°çèªç±è¡ï¼ä¹é²æ¨é½-åä»-ä¼å®ï¼ä¼å®ä¹åï¼åå¤åå¾é¿åæ³°ï¼æ¸¸åææ¯æ¹ï¼ä½çç¤¾ç§é¢éè¯·æåå åå£«åå¼é¢æ¥åï¼æ¶é´å®å¨å½åºèåï¼ä¸è½æ´æ¹ï¼åªå¥½ç»æ­¢æè¡ï¼é£åæé½ãåè®¡åä»å¹´å«æåæ¸¸æ°çï¼ä»å°å·ç´é£é¿åæ³°ï¼ç»æåµå¥¶å¥¶èå´´äºï¼æªè½æè¡ãæå¹´ä¸å®è¦å»ã<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@ç§è±å¾çè°¢ä¸è°¦<!-- raw HTML omitted -->:âæ­¤æ¬¡æ°çæ¸¸ï¼ä¹é²æ¨é½âåä»âä¼å®ï¼åæ¶ä¸¤å¨ï¼å°è±¡æå¥½ï¼ä»åè¿æ³å»ãåµå¥¶å¥¶è¯´è³å°è¿è¦å»ä¸æ¬¡ãå¯¹æä»¬èè¨ï¼å»äºè¿æ³å»çå°æ¹ï¼ç¬¬ä¸æ°çï¼ç¬¬äºäºåï¼ç¬¬ä¸æ­å·ã<!-- raw HTML omitted --> èµéæ¨æ¹å¯¼æ¸¸å°é©¬è¯´ï¼è¯»ä¸å·ä¹¦ä¸å¦è¡ä¸éè·¯ï¼è¡ä¸éè·¯ä¸å¦éäººæ æ°ãä¸è¡ä¸éè·¯ï¼ä½ä»¥éäººæ æ°ï¼å½å¤æ¸¸æä¸ä¸è¯´ï¼å°± &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OyK26ySAz">ä¿ä¹ä¹æï¼æ äººæºå¤§æ¾ç¥å¨ã - è½¬å @æ¯½å®¢éé£é£æ¬:&amp;ensp;#æ¯½å®¢è§çº¿#ä¸é¹èºä¸å¥³è®°èéè®¿äºä¸æ¯ä¼¤äº¡æ¨éçé¨éé«çº§ææ¥å®æ¶ï¼å°åçªç¶ååå¤§å­ï¼æç»ï¼å°åå¨æç»ª...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-oyk26ysaz/">
    
    
    
    
    
      
    
    ä¿ä¹ä¹æï¼æ äººæºå¤§æ¾ç¥å¨ã<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@æ¯½å®¢éé£é£æ¬<!-- raw HTML omitted -->:â<!-- raw HTML omitted --><!-- raw HTML omitted -->#æ¯½å®¢è§çº¿#<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¸é¹èºä¸å¥³è®°èéè®¿äºä¸æ¯ä¼¤äº¡æ¨éçé¨éé«çº§ææ¥å®æ¶ï¼å°åçªç¶ååå¤§å­ï¼æç»ï¼å°åå¨æç»ªç¨³å®åå¯¹å¥¹è¯´äºä¸å¥è¯ï¼æä»¬è¾äºï¼æä»¬ççå¤ªè½åäºï¼è®°èååå­©å­ä¸æ ·ï¼å¯¹ä»è¯´å°åä¸å­ãä¸å­ã<!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OyK9SaRiT">[åå]//@Dreamtraveler2046:æ®å¤§å¸ï¼åºè¯¥å¤§åå¼è¿ä¸­å½ççµå­ç//@åä¸ªå¤§æ³¡æ³¡2024:å¥½åå®³ççå¤´ - è½¬å @æé­007:&amp;ensp;ä¿ç½æ¯çäº§å¦ååé¢ç§èçåå·¥åæµçæ»æ»...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-oyk9sarit/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@Dreamtraveler2046<!-- raw HTML omitted -->:æ®å¤§å¸ï¼åºè¯¥å¤§åå¼è¿ä¸­å½ççµå­ç//<!-- raw HTML omitted -->@åä¸ªå¤§æ³¡æ³¡2024<!-- raw HTML omitted -->:å¥½åå®³ççå¤´<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@æé­007<!-- raw HTML omitted -->:âä¿ç½æ¯çäº§å¦ååé¢ç§èçåå·¥åæµçæ»æ»ï¼ä¿ç½æ¯å°å¤ç«åççï¼è®©ä¿ç½æ¯æåå°æäºæ°æ° &lt;a href=&ldquo;<a href="https://video.weibo.com/show?fid=1034:5078434595143697%22">https://video.weibo.com/show?fid=1034:5078434595143697&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OyKqmbK5e">æææç¬ï¼//@æ´åµ:æè§æ¯åä¸²ãå¸½å­æ´æè¿æ ·ï¼æ¯è¦æ¶èµ·æ¥åå·æ°å¼çã - è½¬å @è¿å¤çå:&amp;ensp;åå¤§æ°å­¦åå£«ï¼æä»¥ä¸ç´è¯´çå·¥ç§éè¦å­¦ç¹äººæç±»ï¼å¾éè¦ãé¡ºä¾¿è¯´...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-oykqmbk5e/">
    
    
    
    
    
      
    
    æææç¬ï¼//<!-- raw HTML omitted -->@æ´åµ<!-- raw HTML omitted -->:æè§æ¯åä¸²ãå¸½å­æ´æè¿æ ·ï¼æ¯è¦æ¶èµ·æ¥åå·æ°å¼çã<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@è¿å¤çå<!-- raw HTML omitted -->:âåå¤§æ°å­¦åå£«ï¼æä»¥ä¸ç´è¯´çå·¥ç§éè¦å­¦ç¹äººæç±»ï¼å¾éè¦ãé¡ºä¾¿è¯´ä¸å¥ï¼åå¤§çæç§ä¸ä¸è¿æ¯å¯ä»¥çã <!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OyKlckyUt">åï¼æ¯é£åä¸æ¬¡é«ä¸­æåç¥­ä¹æ²åå éçå­©å­[ç¬cry] [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oyklckyut/">
    
    
    
    
    
      
    
    åï¼æ¯é£åä¸æ¬¡é«ä¸­æåç¥­ä¹æ²åå éçå­©å­<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OyLJzlBUj">JKä¿ [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oyljzlbuj/">
    
    
    
    
    
      
    
    JKä¿ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OyNICmsgC">å¾å¥½ç - è½¬å @ç ç¾çä¸å±å°ä¿¡ç®±:&amp;ensp;#éªå£ç ç¾##éªå£ç ç¾ins# â° æ¶é´:2024å¹´9æ26æ¥ð¥ Repost @tamami_46_official ââ. ððððããã­ãé«æ ¡...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oynicmsgc/">
    
    
    
    
    
      
    
    å¾å¥½ç<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@ç ç¾çä¸å±å°ä¿¡ç®±<!-- raw HTML omitted -->:â<!-- raw HTML omitted --><!-- raw HTML omitted -->#éªå£ç ç¾#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#éªå£ç ç¾ins#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->â° æ¶é´:2024å¹´9æ26æ¥<!-- raw HTML omitted -->ð¥ Repost &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OyML46Crt">ä¹ä¿å²ç»ªé[ç±ä½ ] - è½¬å @ä¹æ¨å46:&amp;ensp;ãMIZUKI YAMASHITA GRADUATION CONCERTãBlu-ray&amp;DVD2024.10.2 wed. RELEASEð¿ðå±±ä¸åå¤§å®¶çåå¿...ðä¹æ¨å4...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oyml46crt/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OyOlzi738">ä¹ä¿å²ç»ªé#shiorigram# æ¨æå¨ä¹æ¨å46ANNä¸­åçäºä¸ä»¶é¾ä»¥ç½®ä¿¡çäºæãä¹æ¨å46ANN presents ä¹ä¿å²ç·éçéæ¥æåè in æ¨ªæµã¢ãªã¼ã2025å¹´1æ25æ¥ï¼å¨å­ï¼æ¬...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oyolzi738/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extparam=%23shiorigram%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extparam=%23shiorigram%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.npr.org/2024/09/26/1201730546/a-history-of-hezbollah-throwback">A History of Hezbollah (Throwback)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-26</span>
  </div>
  <div class="summary">
    <a href="/post/www-npr-org-2024-09-26-1201730546-a-history-of-hezbollah-throwback/">
    
    
    
    
    
      
    
    Hezbollah is a Lebanese paramilitary organization and political party that&rsquo;s directly supported by the Islamic Republic of Iran. In the wake of the October 7, 2023 Hamas-led attack on Israel, and Israel&rsquo;s invasion of Gaza, there have been escalating attacks between Hezbollah and Israel across the border they share.<!-- raw HTML omitted --><!-- raw HTML omitted -->Today on the show: a history of Hezbollah.<!-- raw HTML omitted --><!-- raw HTML omitted -->Learn more about sponsor message choices: <!-- raw HTML omitted -->podcastchoices.com/adchoices<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->NPR Privacy &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

